July MIMS update

A look at some of the recent changes to the medicines landscape, with new products, presentations, indications and contraindications New Products Etrasimod (as arginine) (Velsipity) is a sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity to S1P receptors 1, 4 and 5 (S1P1, 4, 5). Etrasimod has no activity on S1P2 or S1P3. Etrasimod

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Qld lawyer receives 252 oxycontin scripts...in less than five months
Next Vacancies rise despite 60-day dispensing